CNRGH

Emmanuelle Boscher et al.
Copy Number Variants in miR-138 as a Potential Risk Factor for Early-Onset Alzheimer’s Disease
Journal of Alzheimer's Disease 2019, vol. 68, issue 3
doi: 10.3233/jad-180940

Henri-Corto Stoeklé et al.
Genetic Data, Two-Sided Markets and Dynamic Consent: United States Versus France
Science and Engineering Ethics 2019, vol. 25, issue 5
doi: 10.1007/s11948-019-00085-4

Maëva Veyssiere et al.
A novel nonsense variant in SUPT20H gene associated with Rheumatoid Arthritis identified by Whole Exome Sequencing of multiplex families
PLOS ONE 2019, vol. 14, issue 3
doi: 10.1371/journal.pone.0213387

M. Ibrahim-Kosta et al.
Minor allele of the factor V K858R variant protects from venous thrombosis only in non-carriers of factor V Leiden mutation
Scientific Reports 2019, vol. 9, issue 1
doi: 10.1038/s41598-019-40172-x

Christina Zeitz et al.
Where are the missing gene defects in inherited retinal disorders? Intronic and synonymous variants contribute at least to 4% of CACNA1F ‐mediated inherited retinal disorders
Human Mutation 2019, vol. 40, issue 6
doi: 10.1002/humu.23735

Florian Thibord et al.
OPTIMIR, a novel algorithm for integrating available genome-wide genotype data into miRNA sequence alignment analysis
RNA 2019, vol. 25, issue 6
doi: 10.1261/rna.069708.118

Brian W. Kunkle et al.
Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing
Nature Genetics 2019, vol. 51, issue 3
doi: 10.1038/s41588-019-0358-2

Olivier Fogel et al.
Deregulation of microRNA expression in monocytes and CD4+ T lymphocytes from patients with axial spondyloarthritis
Arthritis Research & Therapy 2019, vol. 21, issue 1
doi: 10.1186/s13075-019-1829-7

Jörg Tost et al.
Immunotherapy-specific miRNA Expression Profiles In Spleenic CD4+ T-cells In A Peanut Sensitized Mouse Model Treated With Oral Or Epicutaneous Immunotherapy
Journal of Allergy and Clinical Immunology 2019, vol. 143, issue 2
doi: 10.1016/j.jaci.2018.12.742

Xavière Lornage et al.
ACTN2 mutations cause “Multiple structured Core Disease” (MsCD)
Acta Neuropathologica 2019, vol. 137, issue 3
doi: 10.1007/s00401-019-01963-8